piboserod,
Piboserod,
152811-62-6,
SB-207266,
UNII-4UQ3S81B25,
SB207256,
N-((1-butylpiperidin-4-yl)methyl)-3,4-dihydro-2H-[1,3]oxazino[3,2-a]indole-10-carboxamide,
4UQ3S81B25,
SB 207266,
N-[(1-butyl-4-piperidinyl)methyl]-3,4-dihydro-2H-[1,3]-oxazino[3,2-a]indole-10-carboxamide,
N-[(1-butylpiperidin-4-yl)methyl]-3,4-dihydro-2H-[1,3]oxazino[3,2-a]indole-10-carboxamide,
Piboserod [INN:BAN],
Serotonin 5-HT4 Receptor Antagonists,
SB207266(Piboserod),
AC1L42OO,
GTPL225,
SCHEMBL467339,
CHEMBL356359,
BDBM85026,
DTXSID60165129,
KVCSJPATKXABRQ-UHFFFAOYSA-N,
BCP15982,
EX-A1189,
ZINC1537633,
MFCD00923681,
PDSP1_001702,
PDSP2_001685,
AKOS015909931,
DB04873,
SB 207266-A,
NCGC00250378-01,
HY-15574,
SB 207256,
FT-0722955,
SB-207266, >=98% (HPLC),
L000973,
I14-31853,
N-(1-Butylpiperidine-4-ylmethyl)-1,2-(trimethyleneoxy)-1H-indole-3-carboxamide,
N-((1-Butyl-4-piperidyl)-methyl)-3,4-dihydro-2H-(1,3)oxazino(3,2-a)indole-10-carboxamide,
N-[(1-Butyl-4-piperidinyl)methyl]-3,4-dihydro-2H-[1,3]-oxazino[3,2-alpha]indole-10-carboxamide,
N-[(1-Butyl4-piperidinyl)methyl]-3,4-dihydro-2H-[1,3]-oxazino[3,2-a]indole-10-carboxamide,
PIBOSEROD,2H-(1,3)OXAZINO(3,2-A)INDOLE-10-CARBOXAMIDE, N-((1-BUTYL-4-PIPERIDINYL)METHYL)-3,4-DIHYDRO-,
Piboserod [INN],
5 HT4 Antagonist,
5-HT4 Antagonist,
5 HT4 Antagonists,
5-HT4 Antagonists,
Antagonist, 5-HT4,
Antagonists, 5-HT4,
D0X2XF,
CID177336,
Serotonin 5 HT4 Receptor Antagonists,
C22-H31-N3-O2,
CS-4311,
A15542,
D058832,
290815-26-8,
2H-[1,3]oxazino[3,2-a]indole-10-carboxamide, N-[(1-butyl-4-piperidinyl)methyl]-3,4-dihydro-,
N-[(1-Butyl-4-piperidinyl)methyl]-3,4-dihydro-2H-[1,3]oxazino[3,2-a]indole-10-carboxamide,